Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Artios Pharma Announces $84M (£65 Million) Series B Financing
Venture Capital

Artios Pharma Announces $84M (£65 Million) Series B Financing

by prnewswire.com posted 1week ago 15 views
CAMBRIDGE, England, August 10, 2018 /PRNewswire/ -- Financing Round Led by New Investors Andera Partners and LSP Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company developing innovative treatments for cancer, today announced the completion of a $84 million (£65...